← Back to All Filings

Intuitive Surgical VP Corporate Controller Exercises Options and Sells $2.38M in Shares Under 10b5-1 Plan

Low SignificanceNovember 2, 2026 at 3:08:31 PM EST

INTUITIVE SURGICAL INC

$ISRG4CIK: 0001035267

Subscribe to track ISRG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Intuitive Surgical Inc ($ISRG) Form 4 Filing Analysis

Insider: Fredrik Widman (VP Corporate Controller) Transaction Date: October 30, 2026 Transaction Type: Option Exercise & Sale (Rule 10b5-1)

Key Details: • Shares Sold: 5,448 shares @ ~$436.06 per share • Total Sale Value: $2,375,628.18 • Options Exercised: 5,448 shares across 14 tranches (strike prices ranging from $79.64 to $347.42) • Shares Retained: 1,026 shares • Trading Plan: Pre-arranged Rule 10b5-1 plan expiring September 15, 2027

Significance: Low (Routine option exercise and liquidation under pre-scheduled plan)

Comprehensive Analysis

Executive Summary

On November 2, 2026, Intuitive Surgical Inc ($ISRG) filed a Form 4 disclosing transactions by Fredrik Widman, VP Corporate Controller. On October 30, 2026, Mr. Widman exercised multiple tranches of non-qualified stock options totaling 5,448 shares and subsequently sold the entirety of the acquired shares for an aggregate consideration of approximately $2.38 million at a weighted average price of $436.0551 per share.

Transaction Breakdown

  1. Derivative Exercises (Code M):

    • Exercised 14 distinct option tranches totaling 5,448 shares of common stock with exercise prices between $79.6378 and $347.4167.
  2. Open Market Sale (Code S):

    • Sold 5,448 shares at a weighted average price of $436.0551 (ranging between $431.64 and $453.60).
    • Gross proceeds: $2,375,628.18.
  3. Post-Transaction Ownership:

    • Following the transactions, Mr. Widman directly owns 1,026 shares of Intuitive Surgical Common Stock.

Governance & Context

  • Rule 10b5-1 Trading Plan: All transactions were conducted pursuant to a pre-established Rule 10b5-1 trading plan expiring on September 15, 2027.
  • Significance Assessment: Low. This represents a routine option exercise and sale program executed under an established 10b5-1 trading plan, reflecting standard executive equity compensation realization rather than an ad-hoc discretionary trade.
Topics:#ISRG#IntuitiveSurgical#InsiderTrading#Form4#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.